Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 271 AL 285

Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study

Spalletta G, Caltagirone C, Padovani A, Sorbi S, Attar M, Colombo D, Cravello L; E V O L U T I O N study Working Group.

PLoS One. 2014 Feb 19;9(2):e89216. doi: 10.1371/journal.pone.0089216. eCollection 2014.

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group; AV45-A11 Study Group.

Mol Psychiatry. 2014 Sep;19(9):1044-51. doi: 10.1038/mp.2014.9. Epub 2014 Mar 11.

Managing patients on antipsychotics: your domain, too

Moore R 2nd, DeJoseph D, Simmons BB.

J Fam Pract. 2014 Mar;63(3):142-9.

Animal models of Alzheimer disease: historical pitfalls and a path forward

Cavanaugh SE, Pippin JJ, Barnard ND.

ALTEX. 2014;31(3):279-302. doi: 10.14573/altex.1310071. Epub 2014 Apr 10.

ATP-binding cassette transporter A1: from metabolism to neurodegeneration

Koldamova R, Fitz NF, Lefterov I.

Neurobiol Dis. 2014 Dec;72 Pt A:13-21. doi: 10.1016/j.nbd.2014.05.007. Epub 2014 May 17.

Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial

Cooper SA, Caslake M, Evans J, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sullivan F.

Trials. 2014 Jun 3;15:202. doi: 10.1186/1745-6215-15-202.

A nutritional approach to ameliorate altered phospholipid metabolism in Alzheimer's disease

Hartmann T, van Wijk N, Wurtman RJ, Olde Rikkert MG, Sijben JW, Soininen H, Vellas B, Scheltens P.

J Alzheimers Dis. 2014;41(3):715-7. doi: 10.3233/JAD-141137.

Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial

Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

PLoS One. 2014 Jun 10;9(6):e98426. doi: 10.1371/journal.pone.0098426. eCollection 2014.

Smoking and increased Alzheimer's disease risk: a review of potential mechanisms

Durazzo TC, Mattsson N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45. doi: 10.1016/j.jalz.2014.04.009.

Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2014;38(5-6):286-99. doi: 10.1159/000362926. Epub 2014 Jul 3.

Vascular cognitive impairment in dementia

Etherton-Beer CD.

Maturitas. 2014 Oct;79(2):220-6. doi: 10.1016/j.maturitas.2014.06.004. Epub 2014 Jun 14.

Increasing burden of Alzheimer's disease by aging

Han SH.

J Korean Med Sci. 2014 Jul;29(7):885. doi: 10.3346/jkms.2014.29.7.885.

Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants

Prasad KN, Bondy SC.

Curr Aging Sci. 2014;7(2):77-90. doi: 10.2174/1874609807666140804115633.

Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease

Edwards SR, Hamlin AS, Marks N, Coulson EJ, Smith MT.

Clin Exp Pharmacol Physiol. 2014 Oct;41(10):798-806. doi: 10.1111/1440-1681.12277.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias